Cost-Utility Analysis of TNF-α Inhibitors, B Cell Inhibitors, and JAK Inhibitors Versus csDMARDs for Rheumatoid Arthritis Treatment
Article in Applied Health Economics and Health Policy (July 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Applied Health Economics and Health Policy (July 2024)
Article in Expert Review of Pharmacoeconomics & Outcomes Research (August 2023)
Article in Frontiers in Pharmacology (December 2022)